Designing a clinical trial to demonstrate prevention of ulcer recurrence: Modelling simulation approaches
- 1 August 1988
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 7 (8), 877-888
- https://doi.org/10.1002/sim.4780070806
Abstract
We describe a Markov chain model for the ulcer recurrence and healing process, review the available literature to obtain appropriate parameter estimates, and use this model to evaluate alternative clinical trial designs. We focus on designs aimed at supporting recurrence prevention claims for a duodenal ulcer maintenance treatment. Our results show that a trial with endoscopies scheduled only at four month intervals is inadequate to support recurrence prevention claims; discrimination between the null and alternative hypotheses is impossible because of the size and direction of expected biases in observed recurrences. Our results suggest that endoscopy intervals should be at most four weeks to establish a claim of ulcer prevention.Keywords
This publication has 9 references indexed in Scilit:
- Nonparametric Methods for Survival/Sacrifice ExperimentsBiometrics, 1986
- The Analysis of Panel Data under a Markov AssumptionJournal of the American Statistical Association, 1985
- Safety of Ranitidine Maintenance Treatment of Duodenal UlcerScandinavian Journal of Gastroenterology, 1984
- Ranitidine in the prevention of gastric and duodenal ulcer relapse.Gut, 1983
- Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects.Gut, 1979
- PREVENTION OF DUODENAL ULCER RELAPSE BY CIMETIDINE: A ONE‐YEAR DOUBLE‐BUND TRIALThe Medical Journal of Australia, 1979
- Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration.Gut, 1979
- PREVENTION BY BEDTIME CIMETIDINE OF DUODENAL-ULCER RELAPSEThe Lancet, 1978
- Cimetidine treatment of duodenal ulcerationGastroenterology, 1978